Hélène Vellemans

Onco-hematology


Dr Hélène VellemansDr. Hélène Vellemans MD

CHU UCL Namur, Site Godinne, Department of Hematology

ResearchGate | LinkedIn

Expertise and research interests

Clinical Hematology

Chronic Lymphocytic Leukemia

Research project(s)

 

Selected publications

ALL PUBLICATIONS IN PUBMED

Sansen PY, Montfort L, Nanquette A, Depaus J, Vellemans H. Complete Remission in a TEMPI Syndrome Treated with a Daratumumab, Lenalidomide, and Dexamethasone-Based Regimen: A Case Report. Case Rep Oncol. 2024 Jan 31;17(1):175-179.

Vellemans H, André MPE. Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma. Cancers (Basel). 2021 Jul 26;13(15):3745.

Vellemans H, André M, Delrée P, Devalet B, Depaus J, Collinge E, Sonet A. Cerebral Toxoplasmosis in a Patient with Chronic Lymphocytic Leukemia Treated With Obinutuzumab-Chlorambucil. Am J Biomed Sci & Res. 2021 - 14(2). AJBSR.MS.ID.001968.

Contact

helene.vellemans@chuuclnamur.uclouvain.be